Jury’s Patent Infringement Verdict Partly Restored in Aseptic Packaging Technology Dispute
January 24, 2025
Steuben Foods, Inc. v. Shibuya Hoppmann Corp Authored by: Jeremy J. Gustrowsky A recent appellate decision has clarified the boundaries of patent infringement and the doctrine of equivalents in the context of aseptic food packaging technology. Steuben Foods, Inc. accused…
Read MoreNavigating Patent Myths: Unlocking Your Business Potential
January 15, 2025
Common misconceptions about the patent system can really hold businesses back from seizing growth opportunities and securing their place in the market, especially when there’s fierce competition out there. One of the biggest myths? “If I patent it, I can…
Read MorePublished Patent Applications Can Be Used as Prior Art in IPRs—Even Before They’re Public
January 14, 2025
Lynk Labs, Inc. v. Samsung Elecs. Co Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit clarified a key question for patent law: Can a published patent application be used as prior art in an inter partes…
Read MorePatent Law Preempts State Claims in BearBox v. Lancium Dispute Over Bitcoin Mining Tech
January 13, 2025
BearBox LLC v. Lancium LLC Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed a win for Lancium LLC in a dispute brought by BearBox LLC and its founder, Austin Storms, over patented technology for managing…
Read MoreFederal Circuit Clarifies Written Description for Drug Combination Patents
January 10, 2025
Novartis Pharms. Corp. v. Torrent Pharma Inc. (In re Entresto (Sacubitril_Valsartan)) Authored by: Jeremy J. Gustrowsky A recent Federal Circuit decision has important implications for pharmaceutical patents covering drug combinations, especially when new forms of those combinations are discovered after…
Read MoreCourt Rejects $85 Million Copyright Damages Demand, Sides with Navy’s “Usage-Based” Approach
January 7, 2025
Bitmanagement Software GmbH v. United States Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed a much smaller damages award for Bitmanagement Software GmbH after the U.S. Navy was found to have infringed its copyright on…
Read MorePatent Board Reversed: Motivation for Obviousness Doesn’t Have to Match Inventor’s Reason
January 2, 2025
Honeywell Int’l Inc. v. 3G Licensing, S.A. Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit reversed the Patent Trial and Appeal Board’s (PTAB) finding that claims of U.S. Patent No. 7,319,718 were not obvious. The patent,…
Read MorePatents on Inhaler Devices Can’t Block Generics: Federal Circuit Clarifies Orange Book Listings
December 20, 2024
Teva Branded Pharm. Prods. R&D, Inc. v. Amneal Pharms. of N.Y., LLC Authored by: Jeremy J. Gustrowsky A recent Federal Circuit decision has big implications for pharmaceutical companies that make combination drug-device products, like inhalers. The court ruled that patents…
Read MoreWho Really “Uses” a Cloud-Based POS System? Federal Circuit Clarifies Direct Infringement in CloudofChange v. NCR
December 18, 2024
Cloudofchange, LLC v. NCR Corp Authored by: Jeremy J. Gustrowsky In a significant decision for technology providers, the Federal Circuit reversed a $13.2 million jury verdict against NCR Corporation, clarifying who can be held liable for patent infringement when a…
Read MoreA “Quotation” Can Trigger the On-Sale Bar: Federal Circuit Invalidates Crown Packaging Patents
December 10, 2024
Crown Packaging Tech., Inc. v. Belvac Prod. Mach., Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit clarified how easily a patent can be invalidated under the “on-sale bar” rule, even when the supposed “offer” is…
Read MorePatent Claims for “Merchants” Limited to Goods, Not Services, in DDR Holdings v. Priceline.com
December 9, 2024
DDR Holdings, LLC v. Priceline.com LLC Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit clarified how patent claims are interpreted when the language changes between a provisional application and the final patent. The case, DDR Holdings,…
Read MoreSolar Cell Antidumping Review Clarifies How Commerce Picks Surrogate Values and Overhead Calculations
December 9, 2024
Risen Energy Co. v. United States Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit addressed how the U.S. Department of Commerce determines antidumping duties for Chinese solar cell exporters, focusing on the use of surrogate values…
Read More